TY  - BOOK
ED  - United States.
TI  - Off-label drug use and FDA review of supplemental drug applications: hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996
AV  - KF27 .G663 1996j
PY  - 1998///
CY  - Washington
PB  - U.S. Government Printing Office
KW  - United States
KW  - Food and Drug Administration
KW  - Rules and practice
KW  - fast
KW  - Drug utilization
KW  - Drug approval
KW  - Drugs
KW  - Labeling
KW  - Government policy
KW  - Prescribing
KW  - Side effects
KW  - Off-Label Use
KW  - Legislative hearings
KW  - lcgft
N1  - CRDP Program record; Includes bibliographical references
UR  - https://purl.fdlp.gov/GPO/gpo119756
ER  -